Invivyd expects to advance VBY329 toward IND readiness in 2H 2026 for development in pediatric RSV prophylaxis, a blockbuster pharmaceutical market in 2024, expected to grow to $3-$4 billion in annual ...
A public health expert explains why the United States is repeating the same mistake with the Hantavirus response as with ...
Dr. Marty Makary's resignation from his post atop the Food and Drug Administration is widening a leadership gap that already ...
During a tumultuous 13-month tenure at the FDA, Makary pursued a wide range of ambitious initiatives. Going forward, their ...
Coding for treatment of certain conditions has surged substantially, and as the Centers for Medicare and Medicaid Services ...
Entered into secured credit agreement with Innoviva for $25 million maturing in 2029 LOS ANGELES, May 13, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ...
Pentagon officials told Congress they estimate the war in Iran has cost $29 billion so far. And, a new Education Scorecard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results